1
|
Maugey N, Lefebvre T, Tournier JN, Neulat-Ripoll F, Chapus C, Grandperret V, Raynaud F, Letois F, Dutasta F, Janvier F, Wolf A, de Laval F. Vaccine efficacy against the SARS-CoV-2 Delta variant during a COVID-19 outbreak aboard a military ship. BMJ Mil Health 2024; 170:91-92. [PMID: 35487589 DOI: 10.1136/bmjmilitary-2022-002082] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Key Words] [MESH Headings] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 01/19/2022] [Accepted: 04/15/2022] [Indexed: 11/03/2022]
Affiliation(s)
- Nancy Maugey
- French Armed Forces Center for Epidemiology and Public Health, Marseille, France
| | - T Lefebvre
- SSA (French Military Health Service), Toulon, France
| | - J-N Tournier
- French Armed Forces Biomedical Research Institute, Brétigny-sur-Orge, France
| | - F Neulat-Ripoll
- French Armed Forces Biomedical Research Institute, Brétigny-sur-Orge, France
| | - C Chapus
- French Armed Forces Biomedical Research Institute, Brétigny-sur-Orge, France
| | - V Grandperret
- French Armed Forces Biomedical Research Institute, Brétigny-sur-Orge, France
| | - F Raynaud
- CBRN Management, French Defense Procurement Agency (DGA), Vert-le-Petit, France
| | - F Letois
- French Armed Forces Center for Epidemiology and Public Health, Marseille, France
| | - F Dutasta
- Sainte Anne Military Teaching Hospital, Toulon, France
| | - F Janvier
- Sainte Anne Military Teaching Hospital, Toulon, France
| | - A Wolf
- Bégin Military Teaching Hospital, Saint-Mandé, France
| | - F de Laval
- French Armed Forces Center for Epidemiology and Public Health, Marseille, France
- Aix-Marseille University, INSERM, IRD, SESSTIM (Economic and Social Sciences, Health Systems, and Medical Informatics), Marseille, France
| |
Collapse
|
2
|
Jousset AB, Bernabeu S, Emeraud C, Bonnin RA, Lomont A, Zahar JR, Merens A, Isnard C, Soismier N, Farfour E, Fihman V, Yin N, Barraud O, Jacquier H, Ranc AG, Laurent F, Corvec S, d'Epenoux LR, Bille E, Degand N, Plouzeau C, Guillard T, Cattoir V, Mizrahi A, Grillon A, Janvier F, Brun CL, Amara M, Bastide M, Lemonnier A, Dortet L. Evaluation of ceftolozane-tazobactam susceptibility on a French nationwide collection of Enterobacterales. J Glob Antimicrob Resist 2023; 32:78-84. [PMID: 36708769 DOI: 10.1016/j.jgar.2023.01.003] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Key Words] [MESH Headings] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 07/26/2022] [Revised: 12/22/2022] [Accepted: 01/13/2023] [Indexed: 01/27/2023] Open
Abstract
OBJECTIVES Ceftolozane-tazobactam (C/T) proved its efficacy for the treatment of infections caused by non-carbapenemase producing Pseudomonas aeruginosa and Enterobacterales. Here, we aimed to provide susceptibility data on a large series of Enterobacterales since the revision of EUCAST categorization breakpoints in 2020. METHODS First, C/T susceptibility was determined on characterized Enterobacterales resistant to third generation cephalosporins (3GCs) (extended spectrum β-lactamase [ESBL] production or different levels of AmpC overexpression) (n = 213) and carbapenem-resistant Enterobacterales (CRE) (n = 259), including 170 carbapenemase producers (CPE). Then, 1632 consecutive clinical Enterobacterales responsible for infection were prospectively collected in 23 French hospitals. C/T susceptibility was determined by E-test® (biomérieux) and broth microdilution (BMD) (Sensititre™, Thermo Scientific) to perform method comparison. RESULTS Within the collection isolates, 88% of 3GC resistant strains were susceptible to C/T, with important variation depending on the resistance mechanism: 93% vs. 13% susceptibility for CTX-M and SHV-ESBL producers, respectively. Only 20% of the CRE were susceptible to C/T. Among CPE, 80% of OXA-48-like producers were susceptible to C/T, whereas all metallo-β-lactamase producers were resistant. The prospective study revealed that 95.6% of clinical isolates were susceptible to C/T. Method comparison performed on these 1632 clinical isolates demonstrated 99% of categorization agreement between MIC to C/T determined by E-test® in comparison with the BMD (reference) and only 74% of essential agreement. CONCLUSION Overall, C/T showed good activity against wild-type Enterobacterales, AmpC producers, and ESBL-producing Escherichia coli but is less active against ESBL-producing Klebsiella pneumoniae, and CRE. E-test® led to an underestimation of the MICs in comparison to the BMD reference.
Collapse
Affiliation(s)
- Agnès B Jousset
- INSERM UMR1184 Team 'Resist', Université Paris-Saclay, Faculté de Médecine, Le Kremlin-Bicêtre, France; Centre National de Référence Associé de la Résistance aux Antibiotiques, Le Kremlin-Bicêtre, France
| | - Sandrine Bernabeu
- INSERM UMR1184 Team 'Resist', Université Paris-Saclay, Faculté de Médecine, Le Kremlin-Bicêtre, France; Centre National de Référence Associé de la Résistance aux Antibiotiques, Le Kremlin-Bicêtre, France
| | - Cécile Emeraud
- INSERM UMR1184 Team 'Resist', Université Paris-Saclay, Faculté de Médecine, Le Kremlin-Bicêtre, France; Centre National de Référence Associé de la Résistance aux Antibiotiques, Le Kremlin-Bicêtre, France; CHU de Bicêtre, Service de Bactériologie-Hygiène, Assistance Publique-Hôpitaux de Paris, Le Kremlin-Bicêtre, France
| | - Rémy A Bonnin
- INSERM UMR1184 Team 'Resist', Université Paris-Saclay, Faculté de Médecine, Le Kremlin-Bicêtre, France; Centre National de Référence Associé de la Résistance aux Antibiotiques, Le Kremlin-Bicêtre, France
| | - Alexandra Lomont
- CHU Avicenne, Service de microbiologie clinique, Assistance Publique-Hôpitaux de Paris, Bobigny, France
| | - Jean Ralph Zahar
- CHU Avicenne, Service de microbiologie clinique, Assistance Publique-Hôpitaux de Paris, Bobigny, France
| | - Audrey Merens
- Hôpital d'Instruction des Armées Begin, Département de Biologie Médicale, Saint Mandé, France
| | - Christophe Isnard
- Normandie Université, UNICAEN/UNIROUEN, DYNAMICURE U1311, CHU de Caen, laboratoire de microbiologie, Caen, France
| | | | - Eric Farfour
- Hôpital Foch, service de Biologie Clinique, Suresnes, France
| | - Vincent Fihman
- CHU Henri Mondor, Unité de Bactériologie-Hygiène, Département de Prévention, Diagnostic et Traitement des infections, Créteil, France
| | - Nicolas Yin
- Institut Gustave Roussy, Service de Bactériologie, Villejuif, France
| | - Olivier Barraud
- CHU Limoges, Service de Bactériologie-Virologie-Hygiène, CIC1435, INSERM 1092, Université de Limoges, UMR, Limoges, France
| | - Hervé Jacquier
- Hôpitaux Universitaires Saint-Louis Lariboisière-Fernand Widal, Service de microbiologie, Assistance Publique-Hôpitaux de Paris, Paris, France
| | - Anne-Gaëlle Ranc
- Hospices Civils de Lyon, Département de Bactériologie, Institut des Agents infectieux, Lyon, France
| | - Frédéric Laurent
- Hospices Civils de Lyon, Département de Bactériologie, Institut des Agents infectieux, Lyon, France
| | - Stéphane Corvec
- CHU de Nantes, Service de Bactériologie et des Contrôles Microbiologiques, Université de Nantes, Inserm, INCIT U1302, Nantes, France
| | - Louise Ruffier d'Epenoux
- CHU de Nantes, Service de Bactériologie et des Contrôles Microbiologiques, Université de Nantes, Inserm, INCIT U1302, Nantes, France
| | - Emmanuelle Bille
- CHU Necker-Enfants Malades, Laboratoire de Microbiologie, Assistance Publique des Hôpitaux de Paris, Paris, France
| | - Nicolas Degand
- CHU Nice, Laboratoire de Bactériologie, Hôpital L'archet 2, Nice, France
| | - Chloé Plouzeau
- CHU de Poitiers, service de Bactériologie et d'Hygiène hospitalière, Unité de microbiologie moléculaire et séquençage, Poitiers, France
| | - Thomas Guillard
- CHU Reims, Hôpital Robert Debré, laboratoire de Bactériologie-Virologie-Hygiène Hospitalière-Parasitologie-Mycologie, Université de Reims-Champagne-Ardenne, Inserm UMR-S 1250 P3Cell, SFR CAP-Santé; Reims, France
| | - Vincent Cattoir
- CHU de Rennes, Service de Bactériologie-Hygiène Hospitalière, Rennes, France
| | - Asaf Mizrahi
- Groupe Hospitalier Paris Saint-Joseph, service de Microbiologie Clinique, Paris, France; Institut Micalis UMR 1319, Université Paris-Saclay, INRAe, AgroParisTech, Châtenay Malabry, France
| | - Antoine Grillon
- CHU de Strasbourg, Plateau Technique de Microbiologie, Laboratoire de Bactériologie, Université de Strasbourg, EA7290, Strasbourg, France
| | - Frédéric Janvier
- Hôpital d'Instruction des Armées Sainte-Anne, Service de microbiologie et hygiène hospitalière, Toulon, France
| | - Cécile Le Brun
- CHRU de Tours, Hôpital Bretonneau, Service de Bactériologie-Virologie-Hygiène, Tours, France
| | - Marlène Amara
- CH Versailles-Site André Mignot, Service de Biologie, Unité de microbiologie, Le Chesnay, France
| | - Mathilda Bastide
- CH Versailles-Site André Mignot, Service de Biologie, Unité de microbiologie, Le Chesnay, France
| | - Alban Lemonnier
- Groupe Hospitalier Paris Saint-Joseph, service de Microbiologie Clinique, Paris, France
| | - Laurent Dortet
- INSERM UMR1184 Team 'Resist', Université Paris-Saclay, Faculté de Médecine, Le Kremlin-Bicêtre, France; Centre National de Référence Associé de la Résistance aux Antibiotiques, Le Kremlin-Bicêtre, France; CHU de Bicêtre, Service de Bactériologie-Hygiène, Assistance Publique-Hôpitaux de Paris, Le Kremlin-Bicêtre, France.
| | | |
Collapse
|
3
|
Magnier A, Gangur D, Seunes C, Broucqsault D, Verhaeghe M, Grebet J, Janvier F, Petit V, Hannebicque G. TAVI eligibility assessment: Interest of a coordinated cardiological and gerontological evaluation. Archives of Cardiovascular Diseases Supplements 2023. [DOI: 10.1016/j.acvdsp.2022.10.154] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 12/31/2022]
|
4
|
Menier L, Bourgea E, Otto MP, Dutasta F, Morand JJ, Janvier F. Cutaneous diphtheria in a patient just returned from Tahiti. Clin Microbiol Infect 2022; 28:1591-1593. [PMID: 35182755 DOI: 10.1016/j.cmi.2022.01.018] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Key Words] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 11/02/2021] [Revised: 01/19/2022] [Accepted: 01/22/2022] [Indexed: 01/26/2023]
Affiliation(s)
- Lucie Menier
- Service De Biologie, Hôpital D'instruction Des Armées Sainte Anne, Toulon, France.
| | - Emilie Bourgea
- Service De Dermatologie, Hôpital D'instruction Des Armées Sainte Anne, Toulon, France
| | - Marie-Pierre Otto
- Service De Biologie, Hôpital D'instruction Des Armées Sainte Anne, Toulon, France
| | - Fabien Dutasta
- Service De Maladies Infectieuses, Hôpital D'instruction Des Armées Sainte Anne, Toulon, France
| | - Jean-Jacques Morand
- Service De Dermatologie, Hôpital D'instruction Des Armées Sainte Anne, Toulon, France; Ecole Du Val-De-Grâce, Formation, Paris, France
| | - Frédéric Janvier
- Service De Biologie, Hôpital D'instruction Des Armées Sainte Anne, Toulon, France; Ecole Du Val-De-Grâce, Formation, Paris, France
| |
Collapse
|
5
|
Boni M, Gorgé O, Mullot JU, Wurtzer S, Moulin L, Maday Y, Obépine G, Canini F, Chantre M, Teyssou R, Maréchal V, Janvier F, Tournier JN. [The French Armed Forces Biomedical Research Institute (IRBA) and wastewater-based epidemiology: Applicability and relevance in armed forces]. Bull Acad Natl Med 2022; 206:1011-1021. [PMID: 36778592 PMCID: PMC9906811 DOI: 10.1016/j.banm.2022.04.025] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Key Words] [Track Full Text] [Figures] [Subscribe] [Scholar Register] [Received: 04/04/2022] [Accepted: 04/29/2022] [Indexed: 11/19/2022]
Abstract
The French Armed Forces Biomedical Research Institute (IRBA) deeply involved in research on SARS-COV-2, participated in the creation of the Obépine sentinel network in charge of detecting, qualifying and quantifying the virus genome in wastewater in France. During this pandemic, wastewater-based epidemiology has proven to be a first class public health tool for assessing viral dynamics in populations and environment. Obépine has also conducted research demonstrating the low infectivity of faeces and wastewater and allowed for early detection of epidemic waves linked to new variants. The IRBA has adapted this powerful tool to the monitoring of viral infections on board the aircraft carrier Charles-de-Gaulle in order to get an operational system for anticipation after the first local outbreak in 2020. The presence of this surveillance and anticipation tool has allowed a better management of SARS-CoV-2 contingent introductions on board during stopovers or crewmembers entries. The combination of a mandatory vaccination protocol and the surveillance of viral circulation in black waters has made it possible to identify and locate cases, and thus to continue the operational mission in the COVID-19 environment while limiting the spread and preserving the health of the crew. This innovative tool can easily be redirected to the search for any other pathogens in blackwater or even, in the long term, to ensure health surveillance of any military establishment, at sea or on land, in France or on overseas bases.
Collapse
Affiliation(s)
- M Boni
- Institut de recherche biomédicale des armées, 1, place Valérie-André, 91220 Brétigny-sur-Orge, France
- Groupement d'intérêt scientifique Obépine, France
| | - O Gorgé
- Institut de recherche biomédicale des armées, 1, place Valérie-André, 91220 Brétigny-sur-Orge, France
| | - J-U Mullot
- Laboratoire d'analyses de surveillance et d'expertise de la Marine, 83000 Toulon, France
- Laboratoire d'analyses de surveillance et d'expertise de la Marine, 83000 Toulon, France
| | - S Wurtzer
- Eau de Paris, département de recherche, développement et qualité de l'eau, 33, avenue Jean-Jaurès, 94200 Ivry-sur-Seine, France
- Groupement d'intérêt scientifique Obépine, France
| | - L Moulin
- Eau de Paris, département de recherche, développement et qualité de l'eau, 33, avenue Jean-Jaurès, 94200 Ivry-sur-Seine, France
- Groupement d'intérêt scientifique Obépine, France
| | - Y Maday
- Sorbonne Université, CNRS, Université de Paris, Laboratoire Jacques-Louis Lions (LJLL), Institut universitaire de France, 75005 Paris, France
- Groupement d'intérêt scientifique Obépine, France
| | - Gis Obépine
- Groupement d'intérêt scientifique Obépine, France
| | - F Canini
- Institut de recherche biomédicale des armées, 1, place Valérie-André, 91220 Brétigny-sur-Orge, France
- École du Val-de-Grâce, 75005 Paris, France
| | - M Chantre
- Institut de recherche biomédicale des armées, 1, place Valérie-André, 91220 Brétigny-sur-Orge, France
| | - R Teyssou
- Institut de recherche biomédicale des armées, 1, place Valérie-André, 91220 Brétigny-sur-Orge, France
- École du Val-de-Grâce, 75005 Paris, France
- Groupement d'intérêt scientifique Obépine, France
| | - V Maréchal
- Sorbonne Université, Inserm, Centre de recherche Saint-Antoine, 75012 Paris, France
- Groupement d'intérêt scientifique Obépine, France
| | - F Janvier
- Hôpital d'instruction des armées Sainte-Anne, service de microbiologie et hygiène hospitalière, 83000 Toulon, France
| | - J-N Tournier
- Institut de recherche biomédicale des armées, 1, place Valérie-André, 91220 Brétigny-sur-Orge, France
- École du Val-de-Grâce, 75005 Paris, France
| |
Collapse
|
6
|
de Laval F, Chaudet H, Gorgé O, Marchi J, Lacrosse C, Dia A, Marbac V, Mmadi Mrenda B, Texier G, Letois F, Chapus C, Sarilar V, Tournier JN, Levasseur A, Cobola J, Nolent F, Dutasta F, Janvier F, Meynard JB, Pommier de Santi V. Investigation of a COVID-19 outbreak on the Charles de Gaulle aircraft carrier, March to April 2020: a retrospective cohort study. Euro Surveill 2022; 27. [PMID: 35620999 PMCID: PMC9137271 DOI: 10.2807/1560-7917.es.2022.27.21.2100612] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Key Words] [Track Full Text] [Download PDF] [Figures] [Subscribe] [Scholar Register] [Indexed: 01/08/2023]
Abstract
Background SARS-CoV-2 emergence was a threat for armed forces. A COVID-19 outbreak occurred on the French aircraft carrier Charles de Gaulle from mid-March to mid-April 2020. Aim To understand how the virus was introduced, circulated then stopped circulation, risk factors for infection and severity, and effectiveness of preventive measures. Methods We considered the entire crew as a cohort and collected personal, clinical, biological, and epidemiological data. We performed viral genome sequencing and searched for SARS-CoV-2 in the environment. Results The attack rate was 65% (1,148/1,767); 1,568 (89%) were included. The male:female ratio was 6.9, and median age was 29 years (IQR: 24–36). We examined four clinical profiles: asymptomatic (13.0%), non-specific symptomatic (8.1%), specific symptomatic (76.3%), and severe (i.e. requiring oxygen therapy, 2.6%). Active smoking was not associated with severe COVID-19; age and obesity were risk factors. The instantaneous reproduction rate (Rt) and viral sequencing suggested several introductions of the virus with 4 of 5 introduced strains from within France, with an acceleration of Rt when lifting preventive measures. Physical distancing prevented infection (adjusted OR: 0.55; 95% CI: 0.40–0.76). Transmission may have stopped when the proportion of infected personnel was large enough to prevent circulation (65%; 95% CI: 62–68). Conclusion Non-specific clinical pictures of COVID-19 delayed detection of the outbreak. The lack of an isolation ward made it difficult to manage transmission; the outbreak spread until a protective threshold was reached. Physical distancing was effective when applied. Early surveillance with adapted prevention measures should prevent such an outbreak.
Collapse
Affiliation(s)
- Franck de Laval
- French Armed Forces Center for Epidemiology and Public Health (CESPA), Marseille, France.,Aix-Marseille University, INSERM, IRD, SESSTIM (Economic and Social Sciences, Health Systems, and Medical Informatics), Marseille, France
| | - Hervé Chaudet
- French Armed Forces Center for Epidemiology and Public Health (CESPA), Marseille, France.,Aix-Marseille University, IRD, AP-HM, SSA (French Military Health Service), VITROME, Marseille, France.,University Hospital Institute Méditerranée Infection, Marseille, France
| | - Olivier Gorgé
- French Armed Forces Biomedical Research Institute (IRBA), Brétigny-sur-Orge, France
| | - Joffrey Marchi
- French Armed Forces Center for Epidemiology and Public Health (CESPA), Marseille, France
| | - Constance Lacrosse
- French Armed Forces Center for Epidemiology and Public Health (CESPA), Marseille, France
| | - Aissata Dia
- French Armed Forces Center for Epidemiology and Public Health (CESPA), Marseille, France
| | | | - Bakridine Mmadi Mrenda
- French Armed Forces Center for Epidemiology and Public Health (CESPA), Marseille, France
| | - Gaëtan Texier
- French Armed Forces Center for Epidemiology and Public Health (CESPA), Marseille, France.,Aix-Marseille University, IRD, AP-HM, SSA (French Military Health Service), VITROME, Marseille, France
| | - Flavie Letois
- French Armed Forces Center for Epidemiology and Public Health (CESPA), Marseille, France
| | - Charles Chapus
- French Armed Forces Biomedical Research Institute (IRBA), Brétigny-sur-Orge, France
| | - Véronique Sarilar
- French Armed Forces Biomedical Research Institute (IRBA), Brétigny-sur-Orge, France
| | | | - Anthony Levasseur
- University Hospital Institute Méditerranée Infection, Marseille, France.,Aix Marseille University, IRD, AP-HM, MEPHI, Marseille, France
| | | | - Flora Nolent
- French Armed Forces Biomedical Research Institute (IRBA), Brétigny-sur-Orge, France
| | | | | | -
- PA-CDG COVID-19 investigation group members are listed under Collaborators
| | - Jean-Baptiste Meynard
- French Armed Forces Center for Epidemiology and Public Health (CESPA), Marseille, France.,Aix-Marseille University, INSERM, IRD, SESSTIM (Economic and Social Sciences, Health Systems, and Medical Informatics), Marseille, France
| | - Vincent Pommier de Santi
- French Armed Forces Center for Epidemiology and Public Health (CESPA), Marseille, France.,Aix-Marseille University, IRD, AP-HM, SSA (French Military Health Service), VITROME, Marseille, France
| |
Collapse
|
7
|
Farfour E, Dortet L, Guillard T, Chatelain N, Poisson A, Mizrahi A, Fournier D, Bonnin RA, Degand N, Morand P, Janvier F, Fihman V, Corvec S, Broutin L, Le Brun C, Yin N, Héry-Arnaud G, Grillon A, Bille E, Jean-Pierre H, Amara M, Jaureguy F, Isnard C, Cattoir V, Diedrich T, Flevin E, Merens A, Jacquier H, Vasse M. Antimicrobial Resistance in Enterobacterales Recovered from Urinary Tract Infections in France. Pathogens 2022; 11:pathogens11030356. [PMID: 35335681 PMCID: PMC8949168 DOI: 10.3390/pathogens11030356] [Citation(s) in RCA: 9] [Impact Index Per Article: 4.5] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Track Full Text] [Download PDF] [Figures] [Journal Information] [Subscribe] [Scholar Register] [Received: 01/31/2022] [Revised: 02/27/2022] [Accepted: 03/10/2022] [Indexed: 12/24/2022] Open
Abstract
In the context of increasing antimicrobial resistance in Enterobacterales, the management of these UTIs has become challenging. We retrospectively assess the prevalence of antimicrobial resistance in Enterobacterales isolates recovered from urinary tract samples in France, between 1 September 2017, to 31 August 2018. Twenty-six French clinical laboratories provided the susceptibility of 134,162 Enterobacterales isolates to 17 antimicrobials. The most frequent species were E. coli (72.0%), Klebsiella pneumoniae (9.7%), Proteus mirabilis (5.8%), and Enterobacter cloacae complex (2.9%). The overall rate of ESBL-producing Enterobacterales was 6.7%, and ranged from 1.0% in P. mirabilis to 19.5% in K. pneumoniae, and from 3.1% in outpatients to 13.6% in long-term care facilities. Overall, 4.1%, 9.3% and 10.5% of the isolates were resistant to cefoxitin, temocillin and pivmecillinam. Cotrimoxazole was the less active compound with 23.4% resistance. Conversely, 4.4%, 12.9%, and 14.3% of the strains were resistant to fosfomycin, nitrofurantoin, and ciprofloxacin. However, less than 1% of E. coli was resistant to fosfomycin and nitrofurantoin. We identified several trends in antibiotics resistances among Enterobacterales isolates recovered from the urinary tract samples in France. Carbapenem-sparing drugs, such as temocillin, mecillinam, fosfomycin, cefoxitin, and nitrofurantoin, remained highly active, including towards ESBL-E.
Collapse
Affiliation(s)
- Eric Farfour
- Service de Biologie Clinique, Hôpital Foch, 92150 Suresnes, France;
- Correspondence: ; Tel.: +33-1-46-25-75-51
| | - Laurent Dortet
- Team RESIST, Laboratoire de Bactériologie-Hygiène, Assistance Publique des Hôpitaux de Paris, Faculté de Médecine, CHU de Bicêtre, Université Paris-Saclay, UMR 1184, 95270 Le Kremlin-Bicêtre, France; (L.D.); (R.A.B.)
| | - Thomas Guillard
- Inserm UMR-S 1250 P3Cell, SFR CAP-Santé, Laboratoire de Bactériologie-Virologie-Hygiène Hospitalière-Parasitologie-Mycologie, Hôpital Robert Debré, CHU Reims, Université de Reims-Champagne-Ardenne, 51000 Reims, France;
| | | | | | - Assaf Mizrahi
- Service de Microbiologie Clinique, Groupe Hospitalier Paris Saint-Joseph, 75015 Paris, France;
- Institut Micalis UMR 1319, Université Paris-Saclay, Institut National de Recherche pour l’Agriculture, l’Alimentation et l’Environnement, AgroParisTech, 92290 Châtenay Malabry, France
| | - Damien Fournier
- Centre National de Référence de la Résistance aux Antibiotiques, Centre Hospitalier Universitaire de Besançon, 25000 Besançon, France;
| | - Rémy A. Bonnin
- Team RESIST, Laboratoire de Bactériologie-Hygiène, Assistance Publique des Hôpitaux de Paris, Faculté de Médecine, CHU de Bicêtre, Université Paris-Saclay, UMR 1184, 95270 Le Kremlin-Bicêtre, France; (L.D.); (R.A.B.)
| | - Nicolas Degand
- Laboratoire de Bactériologie, Centre Hospitalier Universitaire de Nice, 06200 Nice, France;
| | - Philippe Morand
- Service de Bactériologie, AP-HP Centre-Université de Paris, Site Cochin, 75014 Paris, France;
| | | | - Vincent Fihman
- Bacteriology and Infection Control Unit, Department of Prevention, Diagnosis, and Treatment of Infections, AP-HP Centre, Henri-Mondor University Hospital, 94000 Creteil, France;
| | - Stéphane Corvec
- Inserm, Service de Bactériologie et des Contrôles Microbiolgoiques, CHU de Nantes, Université de Nantes, 44000 Nantes, France;
| | - Lauranne Broutin
- Service de Bactériologie et d’Hygiène Hospitalière, Unité de Microbiologie Moléculaire et Séquençage, CHU de Poitiers, 86000 Poitiers, France;
| | - Cécile Le Brun
- Service de Bactériologie, Virologie et Hygiène Hospitalière, CHU de Tours, 37000 Tours, France;
| | - Nicolas Yin
- Department of Microbiology, Laboratoire Hospitalier Universitaire de Bruxelles—Universitair Laboratorium Brussel (LHUB-ULB), Université Libre de Bruxelles (ULB), 1000 Brussels, Belgium;
- Department of Microbiology, Institut Gustave Roussy, Université Paris-Saclay, 94800 Villejuif, France
| | - Geneviève Héry-Arnaud
- Inserm UMR 1078 GGB, Unité de Bactériologie, Hôpital La Cavale Blanche, CHRU de Brest, Université de Brest, CEDEX, 29609 Brest, France;
| | - Antoine Grillon
- Fédération de Médecine Translationnelle de Strasbourg, Institut de Bactériologie, Université de Strasbourg, VBP EA7290, 67000 Strasbourg, France;
| | - Emmanuelle Bille
- Service de Microbiologie, Assistance Publique-Hôpitaux de Paris, Hôpital Necker Enfants-Malades, AP-HP Centre-Université de Paris, 75015 Paris, France;
| | - Hélène Jean-Pierre
- Laboratoire de Bactériologie, Centre Hospitalier Universitaire de Montpellier, 34000 Montpellier, France;
- Maladies Infectieuses et Vecteurs—Écologie, Génétique, Évolution et Contrôle, Centre National pour la Recherche Scientifique, Institut de Recherche pour le Développement, Université de Montpellier, 34000 Montpellier, France
| | - Marlène Amara
- Service de Biologie, Unité de Microbiologie, CH de Versailles, 78150 Le Chesnay, France;
| | - Francoise Jaureguy
- Service de Microbiologie Clinique, Groupe Hospitalier Paris Seine Saint-Denis, AP-HP Centre, CHU Avicenne, 93000 Bobigny, France;
| | - Christophe Isnard
- Department of Microbiology, CHU de Caen Normandie, Normandie University, UNICAEN, 14000 Caen, France;
| | - Vincent Cattoir
- Service de Bactériologie-Hygiène, CHU de Rennes, 35033 Rennes, France;
| | - Tristan Diedrich
- Service de Microbiologie, CH de Valenciennes, 59300 Valenciennes, France;
| | - Emilie Flevin
- Laboratoire de Biologie, CH de Dieppe, 76200 Dieppe, France;
| | - Audrey Merens
- SSA (French Military Health Service), Bégin Military Teaching Hospital, 94160 Saint-Mandé, France;
| | - Hervé Jacquier
- Service de Bactériologie-Virologie, AP-HP Centre, Hôpital Lariboisière, 75010 Paris, France;
| | - Marc Vasse
- Service de Biologie Clinique, Hôpital Foch, 92150 Suresnes, France;
| | | |
Collapse
|
8
|
Paleiron N, Mayet A, Marbac V, Perisse A, Barazzutti H, Brocq FX, Janvier F, Dautzenberg B, Bylicki O. Impact of Tobacco Smoking on the Risk of COVID-19: A Large Scale Retrospective Cohort Study. Nicotine Tob Res 2021; 23:1398-1404. [PMID: 33420786 PMCID: PMC7953961 DOI: 10.1093/ntr/ntab004] [Citation(s) in RCA: 68] [Impact Index Per Article: 22.7] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Track Full Text] [Download PDF] [Figures] [Journal Information] [Subscribe] [Scholar Register] [Received: 07/20/2020] [Accepted: 01/06/2021] [Indexed: 01/08/2023]
Abstract
Introduction Preliminary reports indicated that smokers could be less susceptible to coronavirus SARS-CoV-2, which causes Covid-19. However, once infected an increased risk of severe disease is reported. We investigated the association between smoking and COVID-19 during an outbreak of the disease on a naval vessel. Methods We conducted a cross-sectional, observational study on the 1769 sailors of the same navy aircraft carrier at sea exposed at the same time to SARS-CoV2 to investigate the link between tobacco consumption and Covid-19. Results Among the 1688 crewmembers (87% men; median age = 28 [interquartile range 23–35]) included, 1279 (76%) developed Covid-19 (1038 [62%] reverse-transcriptase- polymerase chain reaction testing–positive and 241 [14%] with only clinical signs). One hundred and seven patients were hospitalized. The univariable analysis odds ratio (OR) for Covid-19 infection was 0.59 (95% confidence interval [CI], 0.45–0.78; p < .001) for current smokers versus former and nonsmokers; sex, body mass index or blood group had no significant impact. Crewmembers >50 years old had an increased risk of contracting Covid-19 (OR, 2.84 [95% CI, 1.30–7.5]; p = .01). Multivariable analysis retained the lower risk of current smokers becoming infected (OR, 0.64 [0.49–0.84]; p < .001) and age >50 years was significatively associated with Covid-19 (OR, 2.6 [1.17–6.9]; p = .03). Conclusions Current smoking status was associated with a lower risk of developing Covid-19 but cannot be considered as efficient protection against infection. The mechanism of the lower susceptibility of smokers to SARS-CoV-2 requires further research. Trial Registration IRB no.: 0011873-2020-09 Implications (1) Recent epidemiologic data suggest a paradoxical link between smoking and COVID-19. (2) Among the 1688 crewmembers (with an attack rate of 76% and exposed at the same time in the same place to SARS-CoV2), we found a significantly lower risk for developing COVID-19 in current smokers (71%) versus former and nonsmokers (80%). This finding strongly supports the need for further research on nicotine physiological pathway and its impact on COVID-19 infection whilst emphasizing that tobacco smoking should not be considered as efficient protection against COVID-19.
Collapse
Affiliation(s)
| | - Aurélie Mayet
- French Military Center for Epidemiology and Public Health (CESPA), Marseille, and UMR 912 SESSTIM: INSERM-IRD-Université Aix-Marseille, Marseille, France
| | | | | | | | | | | | | | | |
Collapse
|
9
|
Lesaca J, Pecoul T, Otto MP, Combes E, Darles C, Benner P, Janvier F. Answer to September 2021 Photo Quiz. J Clin Microbiol 2021; 59:e0298620. [PMID: 34406883 PMCID: PMC8373012 DOI: 10.1128/jcm.02986-20] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Key Words] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/20/2022] Open
Affiliation(s)
- Julien Lesaca
- Service des urgences, Hôpital d’Instruction des Armées Sainte-Anne, Toulon, France
| | - Thomas Pecoul
- Service des urgences, Hôpital d’Instruction des Armées Sainte-Anne, Toulon, France
| | - Marie-Pierre Otto
- Service de microbiologie, Hôpital d’Instruction des Armées Sainte-Anne, Toulon, France
| | - Emmanuel Combes
- Service des urgences, Hôpital d’Instruction des Armées Sainte-Anne, Toulon, France
| | - Chrystelle Darles
- Service de microbiologie, Hôpital d’Instruction des Armées Sainte-Anne, Toulon, France
| | - Patrick Benner
- Service des urgences, Hôpital d’Instruction des Armées Sainte-Anne, Toulon, France
| | - Frédéric Janvier
- Service de microbiologie, Hôpital d’Instruction des Armées Sainte-Anne, Toulon, France
| |
Collapse
|
10
|
Otto MP, Darles C, Valero E, Benner P, Dutasta F, Janvier F. Posterior Oropharyngeal Saliva for the Detection of Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2). Clin Infect Dis 2021; 73:555-557. [PMID: 32770241 PMCID: PMC7454382 DOI: 10.1093/cid/ciaa1181] [Citation(s) in RCA: 10] [Impact Index Per Article: 3.3] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Track Full Text] [Download PDF] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 12/20/2022] Open
Affiliation(s)
- Marie Pierre Otto
- Microbiology and Infection Control Unit, Military Instruction Hospital Sainte Anne, Toulon, France
| | - Chrystelle Darles
- Microbiology and Infection Control Unit, Military Instruction Hospital Sainte Anne, Toulon, France
| | - Elodie Valero
- Microbiology and Infection Control Unit, Military Instruction Hospital Sainte Anne, Toulon, France
| | - Patrick Benner
- Emergency Unit, Military Instruction Hospital Sainte Anne, Toulon, France
| | - Fabien Dutasta
- Internal Medecine Unit, Military Instruction Hospital Sainte Anne, Toulon, France
| | - Frédéric Janvier
- Microbiology and Infection Control Unit, Military Instruction Hospital Sainte Anne, Toulon, France.,School of Val-de-Grâce, Paris, France
| |
Collapse
|
11
|
Guérin F, Dejoies L, Degand N, Guet-Revillet H, Janvier F, Corvec S, Barraud O, Guillard T, Walewski V, Gallois E, Cattoir V. In Vitro Antimicrobial Susceptibility Profiles of Gram-Positive Anaerobic Cocci Responsible for Human Invasive Infections. Microorganisms 2021; 9:microorganisms9081665. [PMID: 34442745 PMCID: PMC8398781 DOI: 10.3390/microorganisms9081665] [Citation(s) in RCA: 5] [Impact Index Per Article: 1.7] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Key Words] [Track Full Text] [Download PDF] [Figures] [Journal Information] [Subscribe] [Scholar Register] [Received: 07/03/2021] [Revised: 07/29/2021] [Accepted: 07/30/2021] [Indexed: 12/14/2022] Open
Abstract
The aim of this multicentre study was to determine the in vitro susceptibility to anti-anaerobic antibiotics of Gram-positive anaerobic cocci (GPAC) isolates responsible for invasive infections in humans. A total of 133 GPAC isolates were collected in nine French hospitals from 2016 to 2020. All strains were identified to the species level (MALDI-TOF mass spectrometry, 16S rRNA sequencing). Minimum inhibitory concentrations (MICs) of amoxicillin, piperacillin, cefotaxime, imipenem, clindamycin, vancomycin, linezolid, moxifloxacin, rifampicin, and metronidazole were determined by the reference agar dilution method. Main erm-like genes were detected by PCR. The 133 GPAC isolates were identified as follows: 10 Anaerococcus spp., 49 Finegoldia magna, 33 Parvimonas micra, 30 Peptoniphilus spp., and 11 Peptostreptococcus anaerobius. All isolates were susceptible to imipenem, vancomycin (except 3 P. micra), linezolid and metronidazole. All isolates were susceptible to amoxicillin and piperacillin, except for P. anaerobius (54% and 45% susceptibility only, respectively). MICs of cefotaxime widely varied while activity of rifampicin, and moxifloxacin was also variable. Concerning clindamycin, 31 were categorized as resistant (22 erm(A) subclass erm(TR), 7 erm(B), 1 both genes and 1 negative for tested erm genes) with MICs from 8 to >32 mg/L. Although GPACs are usually susceptible to drugs commonly used for the treatment of anaerobic infections, antimicrobial susceptibility should be evaluated in vitro.
Collapse
Affiliation(s)
- François Guérin
- Service de Bactériologie-Hygiène Hospitalière, CHU de Rennes, F-35033 Rennes, France; (F.G.); (L.D.)
| | - Loren Dejoies
- Service de Bactériologie-Hygiène Hospitalière, CHU de Rennes, F-35033 Rennes, France; (F.G.); (L.D.)
| | - Nicolas Degand
- Laboratoire de Bactériologie, CHU de Nice, F-06202 Nice, France;
| | | | - Frédéric Janvier
- Service de Microbiologie et Hygiène Hospitalière, Hôpital d’Instruction des Armées Saint-Anne, F-83800 Toulon, France;
| | - Stéphane Corvec
- Service de Bactériologie et des Contrôles Microbiologiques, CHU de Nantes, F-44093 Nantes, France;
| | - Olivier Barraud
- Laboratoire de Bactériologie-Virologie-Hygiène, CHU Dupuytren, F-87042 Limoges, France;
| | - Thomas Guillard
- Laboratoire de Bactériologie-Virologie-Hygiène Hospitalière, Hôpital Robert Debré-CHU de Reims, F-51090 Reims, France;
| | - Violaine Walewski
- Service de Microbiologie, Hôpitaux Universitaires de Paris Seine Denis (HUPSSD), Site Avicenne, AP-HP, F-93000 Bobigny, France;
| | | | - Vincent Cattoir
- Service de Bactériologie-Hygiène Hospitalière, CHU de Rennes, F-35033 Rennes, France; (F.G.); (L.D.)
- Correspondence: ; Tel.: +33-2-99-28-42-76; Fax: +33-2-99-28-41-59
| | | |
Collapse
|
12
|
Nguyen C, Montcriol A, Janvier F, Cungi PJ, Esnault P, Mathais Q, Vallet C, Boussen S, Cordier PY, Serpin L, Papazian L, Bordes J. Critical COVID-19 patient evacuation on an amphibious assault ship: feasibility and safety. A case series. BMJ Mil Health 2021; 167:224-228. [PMID: 32764134 PMCID: PMC7411308 DOI: 10.1136/bmjmilitary-2020-001520] [Citation(s) in RCA: 3] [Impact Index Per Article: 1.0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Key Words] [MESH Headings] [Track Full Text] [Download PDF] [Figures] [Journal Information] [Subscribe] [Scholar Register] [Received: 05/11/2020] [Revised: 07/11/2020] [Accepted: 07/16/2020] [Indexed: 02/06/2023]
Abstract
INTRODUCTION An amphibious assault ship was deployed on 22 March in Corsica to carry out medical evacuation of 12 critical patients infected with COVID-19. The ship has on-board hospital capacity and is the first time that an amphibious assault ship is engaged in this particular condition. The aim is to evaluate the feasibility and safety of prolonged medical evacuation of critical patients with COVID-19. METHODS We included 12 patients with confirmed COVID-19 infection: six ventilated patients with acute respiratory distress syndrome and six non-ventilated patients with hypoxaemia. Transfer on an amphibious assault ship lasted 20 hours. We collected patients' medical records: age, comorbidities, COVID-19 history and diagnosis, ventilation supply and ventilator settings, and blood gas results. We calculated oxygen consumption (OC). RESULTS All patients had a medical history. The median delay from onset of symptoms to hospitalisation was 8 (7-10) days. The median Sequential Organ Failure Assessment score on admission was 3 (2-5). There was no significant increase in oxygen during ship transport and no major respiratory complication. There was no significant increase in arterial oxygen pressure to fractional inspired oxygen ratio among ventilated patients during ship transport. Among ventilated patients, the median calculated OC was 255 L (222-281) by hours and 5270 L (4908-5616) during all ship transport. Among non-ventilated patients, the median calculated OC was 120 L (120-480) by hours and 2400 L (2400-9600) during all ship transport. CONCLUSION The present work contributes to assessing the feasibility and safety condition of critical COVID-19 evacuation on an amphibious assault ship during an extended transport. The ship needs to prepare a plan and a specialised intensive team and conduct patient screening for prolonged interhospital transfers.
Collapse
Affiliation(s)
- Cédric Nguyen
- Anesthesiology and Intensive Care, HIA Sainte Anne, Toulon Armees, France
| | - A Montcriol
- Anesthesiology and Intensive Care, HIA Sainte Anne, Toulon Armees, France
| | - F Janvier
- Anesthesiology and Intensive Care, HIA Sainte Anne, Toulon Armees, France
| | - P-J Cungi
- Anesthesiology and Intensive Care, HIA Sainte Anne, Toulon Armees, France
| | - P Esnault
- Anesthesiology and Intensive Care, HIA Sainte Anne, Toulon Armees, France
| | - Q Mathais
- Anesthesiology and Intensive Care, HIA Sainte Anne, Toulon Armees, France
| | | | - S Boussen
- APHM, Marseille, Provence-Alpes-Côte d'Azur, France
| | - P-Y Cordier
- Anesthesiology and Intensive Care, HIA LAVERAN, Marseille, France
| | - L Serpin
- Emergency, Hospital Centre Ajaccio, Ajaccio, France
| | - L Papazian
- APHM, Marseille, Provence-Alpes-Côte d'Azur, France
| | - J Bordes
- Anesthesiology and Intensive Care, HIA Sainte Anne, Toulon Armees, France
| |
Collapse
|
13
|
Plantamura J, Bousquet A, Otto MP, Bigaillon C, Legland AM, Delacour H, Vest P, Astier H, Valero E, Bylicki O, Renard C, Martin S, Verret C, Garnotel E, Foissaud V, Mérens A, Janvier F. Performances, feasibility and acceptability of nasopharyngeal swab, saliva and oral-self sampling swab for the detection of severe acute respiratory syndrome coronavirus 2. Eur J Clin Microbiol Infect Dis 2021; 40:2191-2198. [PMID: 33987804 PMCID: PMC8118679 DOI: 10.1007/s10096-021-04269-4] [Citation(s) in RCA: 8] [Impact Index Per Article: 2.7] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Key Words] [Download PDF] [Figures] [Journal Information] [Subscribe] [Scholar Register] [Received: 12/21/2020] [Accepted: 05/03/2021] [Indexed: 11/29/2022]
Abstract
Molecular diagnosis on nasopharyngeal swabs (NPS) is the current standard for COVID-19 diagnosis, but saliva may be an alternative specimen to facilitate access to diagnosis. We compared analytic performances, feasibility and acceptability of NPS, saliva, and oral-self sampling swab for the detection of severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2). A prospective, multicenter study was conducted in military hospitals in France among adult outpatients attending COVID-19 diagnosis centers or hospitalized patients. For each patient, all samples were obtained and analyzed simultaneously with RT-PCR or transcription-mediated amplification method. Clinical signs, feasibility, and acceptability for each type of sample were collected. A total of 1220 patients were included, corresponding to 1205 NPS and saliva and 771 OS. Compared to NPS, the sensitivity, specificity, and kappa coefficient for tests performed on saliva were 87.8% (95% CI 83.3–92.3), 97.1% (95% CI 96.1–98.1), and 0.84 (95% CI 0.80–0.88). Analytical performances were better in symptomatic patients. Ct values were significantly lower in NPS than saliva. For OS, sensitivity was estimated to be 61.1% (95% CI 52.7–69.4) and Kappa coefficient to be 0.69 (95% CI 0.62–0.76). OS was the technique preferred by the patients (44.3%) before saliva (42.4%) and NPS (13.4%). Instructions were perceived as simple by patients (> 90%) for saliva and OS. Finally, the painful nature was estimated to be 0.9 for OS, on a scale from 0 to 10, and to be 5.3 for NPS. Performances of OS are not sufficient. Saliva is an acceptable alternative to NPS for symptomatic patient but the process required additional steps to fluidize the sample.
Collapse
Affiliation(s)
- Julie Plantamura
- Microbiology unit, Hôpital d'Instruction des Armées Sainte Anne, Toulon, France
| | - Aurore Bousquet
- Microbiology unit, Hôpital d'Instruction des Armées Bégin, Saint-Mandé, France
| | - Marie-Pierre Otto
- Microbiology unit, Hôpital d'Instruction des Armées Sainte Anne, Toulon, France
| | - Christine Bigaillon
- Microbiology unit, Hôpital d'Instruction des Armées Bégin, Saint-Mandé, France
| | | | - Hervé Delacour
- Microbiology unit, Hôpital d'Instruction des Armées Bégin, Saint-Mandé, France.,Ecole du Val-de-Grâce, Paris, France
| | - Philippe Vest
- Microbiology unit, Hôpital d'Instruction des Armées Percy, Clamart, France
| | - Hélène Astier
- Microbiology unit, Hôpital d'Instruction des Armées Laveran, Marseille, France
| | - Elodie Valero
- Microbiology unit, Hôpital d'Instruction des Armées Sainte Anne, Toulon, France
| | - Olivier Bylicki
- Clinical research unit, Hôpital d'Instruction des Armées Sainte Anne, Toulon, France
| | - Christophe Renard
- Ecole du Val-de-Grâce, Paris, France.,Department of training research training and innovation of French Military Health Service, Val-de-Grâce, Paris, France
| | - Solenne Martin
- Department of training research training and innovation of French Military Health Service, Val-de-Grâce, Paris, France
| | - Catherine Verret
- Department of training research training and innovation of French Military Health Service, Val-de-Grâce, Paris, France
| | - Eric Garnotel
- Ecole du Val-de-Grâce, Paris, France.,Microbiology unit, Hôpital d'Instruction des Armées Laveran, Marseille, France
| | - Vincent Foissaud
- Microbiology unit, Hôpital d'Instruction des Armées Percy, Clamart, France
| | - Audrey Mérens
- Microbiology unit, Hôpital d'Instruction des Armées Bégin, Saint-Mandé, France.,Ecole du Val-de-Grâce, Paris, France
| | - Frédéric Janvier
- Microbiology unit, Hôpital d'Instruction des Armées Sainte Anne, Toulon, France. .,Ecole du Val-de-Grâce, Paris, France.
| |
Collapse
|
14
|
|
15
|
Affiliation(s)
| | | | | | - Fabien Dutasta
- Department of Internal Medicine, HIA Sainte-Anne, Toulon, France
| |
Collapse
|
16
|
Seunes C, Paquet P, Janvier F, Mroueh A, Troux J, Ouadah A, Verhaeghe M, Broucqsault D, Grebet J, Hannebicque G. [Mitral prolapse and sudden death. A case report]. Ann Cardiol Angeiol (Paris) 2020; 69:323-326. [PMID: 33039113 DOI: 10.1016/j.ancard.2020.09.006] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Key Words] [MESH Headings] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 08/11/2020] [Accepted: 09/03/2020] [Indexed: 06/11/2023]
Abstract
The association between the mitral valve prolapse and the sudden Cardiac Death remains controversial, the high prevalence of this valvulopathy contrasting with the low incidence of sudden death in this population. We report the case of a 54-year-old woman admitted for a sudden cardiac death, revealing a bi-prolapse with low-grade leakage, leading to the implantation of a subcutaneous automatic defibrillator. Combined echocardiography and cardiac MRI can identify the mitral annular disjunction, the rolling motion of the posterior face of the mitral annulus towards the myocardium, and the myocardial fibrosis of the inferolateral wall induced by streching forces of the sub valvular apparatus, that may lead to ventricular arrhythmias. More than the conventional clinical parameters (young woman, ventricular premature beats with a right bundle branch block morphology, mitral bi-prolapse), mitral annular disjunction and myocardial fibrosis are to be considered as powerful markers of the rhythmic risk of mitral prolapse and must be systematically sought and integrated into the prognostic evaluation of these patients. In the absence of randomised trials, therapeutic management is difficult especially in primary prevention, and needs Heart Team advice.
Collapse
Affiliation(s)
- C Seunes
- Service de cardiologie, centre hospitalier d'Arras, groupe hospitalier Artois-Ternois, 3, boulevard Besnier, CS 90006, 62022 Arras cedex, France
| | - P Paquet
- Service de cardiologie, centre hospitalier d'Arras, groupe hospitalier Artois-Ternois, 3, boulevard Besnier, CS 90006, 62022 Arras cedex, France
| | - F Janvier
- Service de cardiologie, centre hospitalier d'Arras, groupe hospitalier Artois-Ternois, 3, boulevard Besnier, CS 90006, 62022 Arras cedex, France
| | - A Mroueh
- Service de cardiologie, centre hospitalier d'Arras, groupe hospitalier Artois-Ternois, 3, boulevard Besnier, CS 90006, 62022 Arras cedex, France
| | - J Troux
- Service de cardiologie, centre hospitalier d'Arras, groupe hospitalier Artois-Ternois, 3, boulevard Besnier, CS 90006, 62022 Arras cedex, France
| | - A Ouadah
- Service de cardiologie, centre hospitalier d'Arras, groupe hospitalier Artois-Ternois, 3, boulevard Besnier, CS 90006, 62022 Arras cedex, France
| | - M Verhaeghe
- Service de cardiologie, centre hospitalier d'Arras, groupe hospitalier Artois-Ternois, 3, boulevard Besnier, CS 90006, 62022 Arras cedex, France
| | - D Broucqsault
- Service de cardiologie, centre hospitalier d'Arras, groupe hospitalier Artois-Ternois, 3, boulevard Besnier, CS 90006, 62022 Arras cedex, France
| | - J Grebet
- Service de cardiologie, centre hospitalier d'Arras, groupe hospitalier Artois-Ternois, 3, boulevard Besnier, CS 90006, 62022 Arras cedex, France
| | - G Hannebicque
- Service de cardiologie, centre hospitalier d'Arras, groupe hospitalier Artois-Ternois, 3, boulevard Besnier, CS 90006, 62022 Arras cedex, France.
| |
Collapse
|
17
|
Farfour E, Degand N, Riverain E, Fihman V, Le Brun C, Péan de Ponfilly G, Muggeo A, Jousset A, Piau C, Lesprit P, Chatelain N, Dortet L, Poisson A, Guillard T, Limelette A, Mizrahi A, Le Monnier A, Fournier D, Potron A, Morand P, Janvier F, Otto MP, Woerther PL, Decousser JW, Corvec S, Plouzeau-Jayle C, Broutin L, Yin N, Héry-Arnaud G, Beauruelle C, Grillon A, Lecuru M, Bille E, Godreuil S, Jean Pierre H, Amara M, Henry A, Zahar JR, Carbonelle E, Jaureguy F, Lomont A, Isnard C, Cattoir V, Canis F, Diedrich T, Flevin E, Merens A, Jacquier H, Gyde E. Fosfomycin, from susceptibility to resistance: Impact of the new guidelines on breakpoints. Med Mal Infect 2020; 50:611-616. [DOI: 10.1016/j.medmal.2020.07.003] [Citation(s) in RCA: 2] [Impact Index Per Article: 0.5] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 02/27/2020] [Accepted: 07/08/2020] [Indexed: 12/17/2022]
|
18
|
Huriez P, Cattoir V, Corvec S, Le Brun C, Janvier F, Morand P, Grillon A, Bille E, Le Monnier A, Pilmis B. Caractéristiques des méningites à Klebsiella pneumoniae et Klebsiella oxytoca. Med Mal Infect 2019. [DOI: 10.1016/j.medmal.2019.04.236] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 12/01/2022]
|
19
|
Guillard F, Merens A, Dortet L, Janvier F, Lebrun C, Yin N, Grillon A, Amara M, Jaureguy F, Héry-Arnaud M. Évaluation de la prévalence de la résistance aux antibiotiques chez les entérobactéries isolées de prélèvements urinaires dans les services d’urgence de France. Med Mal Infect 2019. [DOI: 10.1016/j.medmal.2019.04.267] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/16/2022]
|
20
|
Otto MP, Toyer AL, Poggi C, Janvier F. Influenza B false-positive results by rapid molecular tests Alere™ i Influenza A&B 2 in France. Diagn Microbiol Infect Dis 2019; 94:342-343. [PMID: 30971360 DOI: 10.1016/j.diagmicrobio.2019.03.002] [Citation(s) in RCA: 3] [Impact Index Per Article: 0.6] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Key Words] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 01/25/2019] [Revised: 02/28/2019] [Accepted: 03/06/2019] [Indexed: 02/07/2023]
Abstract
The Alere-i™ Influenza A&B (Abbott), a nicking endonuclease amplification reaction test, has recently been improved in order to deliver results in a few minutes. Our field observation highlights two problems with this new version: improper interpretation of a test as valid despite improper reagent hydration and falsely influenza B positive results. We advise users of the new system to check reagent hydration prior to reporting a result and to systematically confirm positive influenza B results.
Collapse
Affiliation(s)
- Marie Pierre Otto
- Service de microbiologie, Hôpital d'Instruction des Armées Sainte Anne, Toulon, France
| | - Anne-Lise Toyer
- Service de biologie, C.H.I Toulon la Seyne sur mer, Toulon, France
| | - Cécile Poggi
- Service de biologie, C.H.I Toulon la Seyne sur mer, Toulon, France
| | - Frédéric Janvier
- Service de microbiologie, Hôpital d'Instruction des Armées Sainte Anne, Toulon, France; Ecole du Val-de-Grâce, Paris, France.
| |
Collapse
|
21
|
Savini H, Janvier F, Karkowski L, Billhot M, Aletti M, Bordes J, Koulibaly F, Cordier PY, Cournac JM, Maugey N, Gagnon N, Cotte J, Cambon A, Mac Nab C, Moroge S, Rousseau C, Foissaud V, De Greslan T, Granier H, Cellarier G, Valade E, Kraemer P, Alla P, Mérens A, Sagui E, Carmoi T, Rapp C. Occupational Exposures to Ebola Virus in Ebola Treatment Center, Conakry, Guinea. Emerg Infect Dis 2018; 23:1380-1383. [PMID: 28726614 PMCID: PMC5547773 DOI: 10.3201/eid2308.161804] [Citation(s) in RCA: 9] [Impact Index Per Article: 1.5] [Reference Citation Analysis] [What about the content of this article? (0)] [Abstract] [Key Words] [MESH Headings] [Track Full Text] [Download PDF] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 02/03/2023] Open
Abstract
We report 77 cases of occupational exposures for 57 healthcare workers at the Ebola Treatment Center in Conakry, Guinea, during the Ebola virus disease outbreak in 2014−2015. Despite the high incidence of 3.5 occupational exposures/healthcare worker/year, only 18% of workers were at high risk for transmission, and no infections occurred.
Collapse
|
22
|
Ernest V, Janvier F, Richecoeur T, Tortat A, Mettler C, Terrier J, Cambon A, Poisnel E, Dutasta F, Paris J, Defuentes G. Adénite à Propionibacterium (Cutibacterium) : deux observations. Rev Med Interne 2017. [DOI: 10.1016/j.revmed.2017.10.255] [Citation(s) in RCA: 1] [Impact Index Per Article: 0.1] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/24/2022]
|
23
|
Poisnel E, Janvier F, Pangnarind V, Villetard-Gutierrez F, Jammot E, Cambon A, Defuentes G, Paris JF. Abcès froids multiples récidivants : se souvenir du « mal royal » ! Rev Med Interne 2016. [DOI: 10.1016/j.revmed.2016.10.191] [Citation(s) in RCA: 1] [Impact Index Per Article: 0.1] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/25/2022]
|
24
|
Cambon A, Janvier F, Villetard-Gutierrez F, Jammot E, Pangnarind V, Poisnel E, Paris J, Defuentes G. Élévation majeure de la procalcitonine au cours d’un choc : ne pas se borner au sepsis ! Rev Med Interne 2016. [DOI: 10.1016/j.revmed.2016.10.185] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 10/20/2022]
|
25
|
Janvier F, Delaune D, Poyot T, Valade E, Mérens A, Rollin PE, Foissaud V. Ebola Virus RNA Stability in Human Blood and Urine in West Africa's Environmental Conditions. Emerg Infect Dis 2016; 22:292-4. [PMID: 26812135 PMCID: PMC4734543 DOI: 10.3201/eid2202.151395] [Citation(s) in RCA: 13] [Impact Index Per Article: 1.6] [Reference Citation Analysis] [What about the content of this article? (0)] [Abstract] [Key Words] [MESH Headings] [Track Full Text] [Download PDF] [Figures] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/19/2022] Open
Abstract
We evaluated RNA stability of Ebola virus in EDTA blood and urine samples collected from infected patients and stored in West Africa's environmental conditions. In blood, RNA was stable for at least 18 days when initial cycle threshold values were <30, but in urine, RNA degradation occurred more quickly.
Collapse
|
26
|
Janvier F, Otto MP, Jové T, Mille A, Contargyris C, Meaudre E, Brisou P, Plésiat P, Jeannot K. A case of multiple contamination with methylase ArmA-producing pathogens. J Antimicrob Chemother 2016; 72:618-620. [PMID: 28073962 DOI: 10.1093/jac/dkw418] [Citation(s) in RCA: 7] [Impact Index Per Article: 0.9] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/12/2022] Open
Affiliation(s)
- F Janvier
- Service de Microbiologie-Hygiène, Hôpital d'Instruction des Armées Sainte Anne, Toulon, France
| | - M-P Otto
- Service de Microbiologie-Hygiène, Hôpital d'Instruction des Armées Sainte Anne, Toulon, France
| | - T Jové
- Université de Limoges, INSERM, CHU Limoges, UMR_S 1092, F-87000 Limoges, France
| | - A Mille
- Laboratoire de Bactériologie, Centre National de Référence de la Résistance aux Antibiotiques, Hôpital Universitaire de Besançon, boulevard Fleming, 25000, Besançon, France
| | - C Contargyris
- Service d'Anesthésie-Réanimation-Soins Continus, Hôpital d'Instruction des Armées Sainte Anne, Toulon, France
| | - E Meaudre
- Service d'Anesthésie-Réanimation-Soins Continus, Hôpital d'Instruction des Armées Sainte Anne, Toulon, France
| | - P Brisou
- Service de Microbiologie-Hygiène, Hôpital d'Instruction des Armées Sainte Anne, Toulon, France
| | - P Plésiat
- Laboratoire de Bactériologie, Centre National de Référence de la Résistance aux Antibiotiques, Hôpital Universitaire de Besançon, boulevard Fleming, 25000, Besançon, France
| | - K Jeannot
- Laboratoire de Bactériologie, Centre National de Référence de la Résistance aux Antibiotiques, Hôpital Universitaire de Besançon, boulevard Fleming, 25000, Besançon, France
| |
Collapse
|
27
|
Jayol A, Janvier F, Guillard T, Chau F, Mérens A, Robert J, Fantin B, Berçot B, Cambau E. qnrA6genetic environment and quinolone resistance conferred onProteus mirabilis. J Antimicrob Chemother 2016; 71:903-8. [DOI: 10.1093/jac/dkv431] [Citation(s) in RCA: 4] [Impact Index Per Article: 0.5] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 08/05/2015] [Accepted: 11/12/2015] [Indexed: 11/13/2022] Open
|
28
|
Grélot L, Koulibaly F, Maugey N, Janvier F, Foissaud V, Aletti M, Savini H, Cotte J, Dampierre H, Granier H, Carmoi T, Sagui E. Moderate Thermal Strain in Healthcare Workers Wearing Personal Protective Equipment During Treatment and Care Activities in the Context of the 2014 Ebola Virus Disease Outbreak. J Infect Dis 2015; 213:1462-5. [PMID: 26655297 DOI: 10.1093/infdis/jiv585] [Citation(s) in RCA: 23] [Impact Index Per Article: 2.6] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Key Words] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 09/15/2015] [Accepted: 11/27/2015] [Indexed: 11/14/2022] Open
Abstract
The extent of thermal strain while wearing personal protective equipment (PPE) during care activities for Ebola virus disease patients has not yet been characterized. From January to March 2015, 25 French healthcare workers (HCWs) in Conakry, Guinea, volunteered to be monitored while wearing PPE using an ingestible thermal sensor. The mean (standard deviation) working ambient temperature and relative humidity were 29.6 °C (2.0 °C) and 65.4% (10.3%), respectively; the mean time wearing PPE was 65.7 (13.5) minutes; and the mean core body temperature increased by 0.46 °C (0.20 °C). Four HCWs reached or exceeded a mean core body temperature of ≥ 38.5 °C. HCWs wearing PPE for approximately 1 hour exhibited moderate but safe thermal strain.
Collapse
Affiliation(s)
| | | | | | - Frédéric Janvier
- French Military Teaching Hospital Saint Anne, Biological Department, Toulon
| | - Vincent Foissaud
- French Military Teaching Hospital Percy, Internal Medicine Department, Clamart
| | - Marc Aletti
- French Military Teaching Hospital Percy, Internal Medicine Department, Clamart
| | - Hélène Savini
- French Military Teaching Hospital Laveran, Neurological Department, Marseille
| | - Jean Cotte
- French Military Teaching Hospital Saint Anne, Biological Department, Toulon
| | - Henry Dampierre
- French Forces Health Services, Fort Neuf de Vincennes, Cours des Maréchaux
| | - Hervé Granier
- French Military Teaching Hospital Clermont Tonnerre, Internal Medicine Department, Brest
| | - Thierry Carmoi
- French Military Teaching Hospital Val de Grâce, Internal Medicine Department Val de Grâce Military Academy, Paris, France
| | - Emmanuel Sagui
- Aix-Marseille University, Marseille French Military Teaching Hospital Laveran, Neurological Department, Marseille Val de Grâce Military Academy, Paris, France
| |
Collapse
|
29
|
Affiliation(s)
| | - Emmanuel Sagui
- Healthcare Workers Ebola Treatment Center, Conakry, Guinea
| | | |
Collapse
|
30
|
Cotte J, Janvier F, Cordier PY, Bordes J, Kaiser E. Organ support in Ebola virus disease: Utility of point-of-care blood tests. Anaesth Crit Care Pain Med 2015; 34:363-4. [DOI: 10.1016/j.accpm.2015.04.007] [Citation(s) in RCA: 4] [Impact Index Per Article: 0.4] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 03/21/2015] [Accepted: 04/16/2015] [Indexed: 10/22/2022]
|
31
|
Janvier F, Foissaud V, Delaune D, Flusin O, Dubrous P, Mac Nab C, Gaillard T, Perez P, Poyot T, Paucod JC, Richard S, Ferraris O, Delacour H, Bigaillon C, Leparc-Goffard I, Peyrefitte C, Brisou P, Renard C, Garnotel E, Koeck JL, Thibault F, Valade E, Mérens A. Deployment of the French Military Field Laboratory Dedicated to Ebola Virus Infected Patients in Guinea, January-July 2015. J Infect Dis 2015; 213:1208-9. [PMID: 26597257 DOI: 10.1093/infdis/jiv554] [Citation(s) in RCA: 7] [Impact Index Per Article: 0.8] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 08/25/2015] [Accepted: 11/13/2015] [Indexed: 11/13/2022] Open
Affiliation(s)
- Frédéric Janvier
- Centre de Traitement des Soignants, Conakry, Guinea Hôpital d'Instruction des Armées Ste Anne, Toulon
| | - Vincent Foissaud
- Centre de Traitement des Soignants, Conakry, Guinea Hôpital d'Instruction des Armées Percy, Clamart
| | - Deborah Delaune
- Centre de Traitement des Soignants, Conakry, Guinea Hôpital d'Instruction des Armées Bégin, St Mandé
| | - Olivier Flusin
- Centre de Traitement des Soignants, Conakry, Guinea Institut de Recherche Biomédicale des Armées, Brétigny-sur-Orge
| | - Philippe Dubrous
- Centre de Traitement des Soignants, Conakry, Guinea Hôpital d'Instruction des Armées Robert Picqué, Villenave d'Ornon
| | - Christine Mac Nab
- Centre de Traitement des Soignants, Conakry, Guinea Hôpital d'Instruction des Armées Percy, Clamart
| | - Tiphaine Gaillard
- Centre de Traitement des Soignants, Conakry, Guinea Hôpital d'Instruction des Armées Ste Anne, Toulon
| | | | - Thomas Poyot
- Institut de Recherche Biomédicale des Armées, Brétigny-sur-Orge
| | | | | | | | | | | | | | | | | | | | - Eric Garnotel
- Ecole du Val-de-Grâce, Paris Hôpital d'Instruction des Armées Lavéran, Marseille
| | - J-L Koeck
- Hôpital d'Instruction des Armées Robert Picqué, Villenave d'Ornon Ecole du Val-de-Grâce, Paris
| | - François Thibault
- Direction Centrale du Service de Santé des Armées, Vincennes, France
| | - Eric Valade
- Institut de Recherche Biomédicale des Armées, Brétigny-sur-Orge Ecole du Val-de-Grâce, Paris
| | - Audrey Mérens
- Hôpital d'Instruction des Armées Bégin, St Mandé Ecole du Val-de-Grâce, Paris
| |
Collapse
|
32
|
Janvier F, Foissaud V, Cotte J, Aletti M, Savini H, Cordier PY, Maugey N, Duron S, Koulibaly F, Granier H, Carmoi T, Sagui E. Monitoring of Prognostic Laboratory Markers in Ebola Virus Disease. J Infect Dis 2015; 213:1049. [PMID: 26582958 DOI: 10.1093/infdis/jiv546] [Citation(s) in RCA: 8] [Impact Index Per Article: 0.9] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 07/10/2015] [Accepted: 11/09/2015] [Indexed: 11/15/2022] Open
Affiliation(s)
| | | | - Jean Cotte
- Healthcare Workers Ebola Treatment Center, Conakry, Guinea
| | | | - Marc Aletti
- Healthcare Workers Ebola Treatment Center, Conakry, Guinea
| | - Hélène Savini
- Healthcare Workers Ebola Treatment Center, Conakry, Guinea
| | | | - Nancy Maugey
- Healthcare Workers Ebola Treatment Center, Conakry, Guinea
| | - Sandrine Duron
- Healthcare Workers Ebola Treatment Center, Conakry, Guinea
| | | | - Hervé Granier
- Healthcare Workers Ebola Treatment Center, Conakry, Guinea
| | - Thierry Carmoi
- Healthcare Workers Ebola Treatment Center, Conakry, Guinea
| | - Emmanuel Sagui
- Healthcare Workers Ebola Treatment Center, Conakry, Guinea
| |
Collapse
|
33
|
Cournac JM, Karkowski L, Bordes J, Aletti M, Duron S, Janvier F, Foissaud V, Savini H, de Greslan T, Rousseau C, Billhot M, Gagnon N, Mac Nab C, Dubrous P, Moroge S, Broto H, Cotte J, Maugey N, Cordier PY, Sagui E, Merens A, Rapp C, Quentin B, Granier H, Carmoi T, Cellarier G. Rhabdomyolysis in Ebola Virus Disease. Results of an Observational Study in a Treatment Center in Guinea. Clin Infect Dis 2015; 62:19-23. [PMID: 26338789 DOI: 10.1093/cid/civ779] [Citation(s) in RCA: 28] [Impact Index Per Article: 3.1] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Key Words] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 05/06/2015] [Accepted: 08/20/2015] [Indexed: 12/18/2022] Open
Abstract
BACKGROUND The pathogenesis of Ebola virus disease (EVD) remains unclear. The sporadic nature of Ebola outbreaks and their occurrence in resource-limited settings have precluded the acquisition of extensive clinical and laboratory data. Rhabdomyolysis during EVD has been suggested to occur in previous studies showing increased aspartate aminotransferase-alanine aminotransferase ratios, but, to date, has not been confirmed with creatine kinase (CK) assays. METHODS We performed an observational study of 38 patients admitted to an Ebola treatment center from January to April 2015. CK values from patients with confirmed EVD were compared with those in patients without confirmed EVD. A panel of other analyses were also performed. In patients with EVD, characteristics were compared between survivors and nonsurvivors. RESULTS High levels of CK were more frequent in patients with EVD than in those without (P = .002), and rhabdomyolysis was more frequent (59% vs 19%, respectively; P = .03). CK levels >5000 U/L were observed in 36% of patients with EVD. Also in patients with EVD, fatal outcome was significantly associated with higher creatinine and bilirubin levels, international normalized ratio, and viral load. CONCLUSIONS Rhabdomyolysis is a frequent disorder in EVD and seems to be more common than in other viral infections. It may contribute to the renal failure observed in nonsurviving patients. More studies are needed to determine the impact of rhabdomyolysis on EVD outcome.
Collapse
Affiliation(s)
- Jean Marie Cournac
- French Military Ebola Virus Disease Treatment Centre, Conakry, Guinea Percy Military Teaching Hospital, Clamart
| | - Ludovic Karkowski
- French Military Ebola Virus Disease Treatment Centre, Conakry, Guinea Legouest Military Teaching Hospital, Metz
| | - Julien Bordes
- French Military Ebola Virus Disease Treatment Centre, Conakry, Guinea Sainte Anne Military Teaching Hospital, Toulon
| | - Marc Aletti
- French Military Ebola Virus Disease Treatment Centre, Conakry, Guinea Percy Military Teaching Hospital, Clamart
| | - Sandrine Duron
- French Military Ebola Virus Disease Treatment Centre, Conakry, Guinea French Military Center for Epidemiology and Public Health
| | - Frédéric Janvier
- French Military Ebola Virus Disease Treatment Centre, Conakry, Guinea Sainte Anne Military Teaching Hospital, Toulon
| | - Vincent Foissaud
- French Military Ebola Virus Disease Treatment Centre, Conakry, Guinea Percy Military Teaching Hospital, Clamart
| | - Hélène Savini
- French Military Ebola Virus Disease Treatment Centre, Conakry, Guinea Laveran Military Teaching Hospital, Marseille
| | - Thierry de Greslan
- French Military Ebola Virus Disease Treatment Centre, Conakry, Guinea Val De Grâce Military Teaching Hospital
| | - Claire Rousseau
- French Military Ebola Virus Disease Treatment Centre, Conakry, Guinea Clermont Tonnerre Military Teaching Hospital, Brest
| | - Magali Billhot
- French Military Ebola Virus Disease Treatment Centre, Conakry, Guinea Val De Grâce Military Teaching Hospital
| | - Nicolas Gagnon
- French Military Ebola Virus Disease Treatment Centre, Conakry, Guinea Legouest Military Teaching Hospital, Metz
| | - Christine Mac Nab
- French Military Ebola Virus Disease Treatment Centre, Conakry, Guinea Percy Military Teaching Hospital, Clamart
| | - Philippe Dubrous
- French Military Ebola Virus Disease Treatment Centre, Conakry, Guinea Robert Picqué Military Teaching Hospital, Bordeaux
| | - Sophie Moroge
- French Military Ebola Virus Disease Treatment Centre, Conakry, Guinea Laveran Military Teaching Hospital, Marseille
| | - Helene Broto
- French Military Ebola Virus Disease Treatment Centre, Conakry, Guinea French Military Center for Health Supplies, Orléans
| | - Jean Cotte
- French Military Ebola Virus Disease Treatment Centre, Conakry, Guinea Sainte Anne Military Teaching Hospital, Toulon
| | - Nancy Maugey
- French Military Ebola Virus Disease Treatment Centre, Conakry, Guinea French Military Health Service Surgeon General Office, Paris
| | - Pierre-Yves Cordier
- French Military Ebola Virus Disease Treatment Centre, Conakry, Guinea Laveran Military Teaching Hospital, Marseille
| | - Emmanuel Sagui
- French Military Ebola Virus Disease Treatment Centre, Conakry, Guinea Laveran Military Teaching Hospital, Marseille
| | - Audrey Merens
- French Military Ebola Virus Disease Treatment Centre, Conakry, Guinea Bégin Military Teaching Hospital, Saint-Mandé, France
| | - Christophe Rapp
- French Military Ebola Virus Disease Treatment Centre, Conakry, Guinea Bégin Military Teaching Hospital, Saint-Mandé, France
| | - Benoit Quentin
- French Military Ebola Virus Disease Treatment Centre, Conakry, Guinea French Military Health Service Surgeon General Office, Paris
| | - Hervé Granier
- French Military Ebola Virus Disease Treatment Centre, Conakry, Guinea Clermont Tonnerre Military Teaching Hospital, Brest
| | - Thierry Carmoi
- French Military Ebola Virus Disease Treatment Centre, Conakry, Guinea Val De Grâce Military Teaching Hospital
| | - Gilles Cellarier
- French Military Ebola Virus Disease Treatment Centre, Conakry, Guinea Sainte Anne Military Teaching Hospital, Toulon
| |
Collapse
|
34
|
Sagui E, Janvier F, Baize S, Foissaud V, Koulibaly F, Savini H, Maugey N, Aletti M, Granier H, Carmoi T. Severe Ebola Virus Infection With Encephalopathy: Evidence for Direct Virus Involvement. Clin Infect Dis 2015. [PMID: 26197842 DOI: 10.1093/cid/civ606] [Citation(s) in RCA: 34] [Impact Index Per Article: 3.8] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/13/2022] Open
Affiliation(s)
- Emmanuel Sagui
- French Military Teaching Hospital Laveran, Department of Neurology, Marseille Aix Marseille University, Centre National de la Recherche Scientifique, Laboratoire de Neurosciences cognitives, Unité Mixte de Recherche 7291, Marseille Val de Grâce Military School, Paris
| | - Frédéric Janvier
- French Military Teaching Hospital Saint Anne, Department of Biology, Toulon
| | - Sylvain Baize
- National Reference Center for Viral Hemorrhagic Fevers Unité de Biologie des Infections Virales Emergentes, Institut Pasteur Centre International de Recherche en Infectiologie, Lyon University, Institut National de la Santé et de la Recherche Médicale 1111, Ecole Normale Supérieure de Lyon, Lyon University 1, Villeurbanne
| | - Vincent Foissaud
- French Military Teaching Hospital Percy, Department of Biology, Clamard, France
| | | | - Hélène Savini
- French Military Teaching Hospital Laveran, Department of Neurology, Marseille
| | | | - Marc Aletti
- French Military Teaching Hospital Percy, Department of Biology, Clamard, France
| | - Hervé Granier
- French Military Teaching Hospital Clermont Tonnerre, Brest
| | - Thierry Carmoi
- French Military Teaching Hospital Val de Grâce, Department of Internal Medicine, Paris, France
| |
Collapse
|
35
|
Bordes J, Janvier F, Aletti M, de Greslan T, Gagnon N, Cotte J, Rousseau C, Billhot M, Cournac JM, Karkowski L, Moroge S, Duron S, Carmoi T, Cellarier G. Organ failures on admission in patients with Ebola virus disease. Intensive Care Med 2015; 41:1504-5. [PMID: 26134358 DOI: 10.1007/s00134-015-3912-0] [Citation(s) in RCA: 4] [Impact Index Per Article: 0.4] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Accepted: 06/03/2015] [Indexed: 12/01/2022]
Affiliation(s)
- Julien Bordes
- French Military Ebola Virus Disease Treatment Centre, Conakry, Guinea,
| | | | | | | | | | | | | | | | | | | | | | | | | | | |
Collapse
|
36
|
Aletti M, Janvier F, Savini H, Maugey N, Sagui E, Carmoi T. [Ebola virus disease]. Rev Prat 2015; 65:758. [PMID: 26298893] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [MESH Headings] [Subscribe] [Scholar Register] [Indexed: 06/04/2023]
|
37
|
Janvier F, Gorbatch S, Queval L, Top J, Vigier C, Cotte J, Foissaud V. Difficulties of interpretation of Zaire Ebola Virus PCR results and implication in the field. J Clin Virol 2015; 67:36-7. [PMID: 25959155 DOI: 10.1016/j.jcv.2015.04.001] [Citation(s) in RCA: 13] [Impact Index Per Article: 1.4] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [MESH Headings] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 03/20/2015] [Revised: 03/28/2015] [Accepted: 04/02/2015] [Indexed: 11/19/2022]
Affiliation(s)
- Frédéric Janvier
- Laboratory, Centre de Traitement des Soignants, Conakry, Guinea; Department of Microbiology, Hôpital d'Instruction des Armées Sainte Anne, Toulon, France.
| | - Sophie Gorbatch
- Laboratory, Centre de Traitement des Soignants, Conakry, Guinea; Department of microbiology, Hôpital d'Instruction des Armées Laveran, Marseille, France
| | - Lucie Queval
- Laboratory, Centre de Traitement des Soignants, Conakry, Guinea; Department of biology, Hôpital d'Instruction des Armées Percy, Clamart, France
| | - Julie Top
- Laboratory, Centre de Traitement des Soignants, Conakry, Guinea; Department of microbiology, Hôpital d'Instruction des Armées Sainte Anne, Toulon, France
| | - Cécile Vigier
- Laboratory, Centre de Traitement des Soignants, Conakry, Guinea; Institut de Recherche Biomédical des Armées, Brétigny sur Orge, France
| | - Jean Cotte
- Laboratory, Centre de Traitement des Soignants, Conakry, Guinea
| | - Vincent Foissaud
- Laboratory, Centre de Traitement des Soignants, Conakry, Guinea; Department of biology, Hôpital d'Instruction des Armées Percy, Clamart, France
| |
Collapse
|
38
|
Delarbre D, Poisnel E, Janvier F, Pons S, Delavergne C, Landais C, Paris J, Graffin B. Les manifestations inaugurales de la scléromyosite : à propos de quatre observations. Rev Med Interne 2014. [DOI: 10.1016/j.revmed.2014.03.188] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/26/2022]
|
39
|
Janvier F, Delacour H, Tessé S, Larréché S, Sanmartin N, Ollat D, Rapp C, Mérens A. Faecal carriage of extended-spectrum β-lactamase-producing enterobacteria among soldiers at admission in a French military hospital after aeromedical evacuation from overseas. Eur J Clin Microbiol Infect Dis 2014; 33:1719-23. [PMID: 24807441 DOI: 10.1007/s10096-014-2141-8] [Citation(s) in RCA: 17] [Impact Index Per Article: 1.7] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [MESH Headings] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 02/12/2014] [Accepted: 04/24/2014] [Indexed: 11/28/2022]
Abstract
The aim of this study was to assess the faecal carriage of carbapenemase-producing enterobacteria (CPE) and extended-spectrum β-lactamase (ESBL)-producing enterobacteria among soldiers at admission in a French military hospital after aeromedical evacuation from overseas. During a period of 1 year, 83 rectal swabs collected in French soldiers at admission were screened for multidrug-resistant enterobacteria with a chromogenic medium. ESBL detection was performed with the double-disc synergy test in the absence or presence of cloxacillin. The genotypic characterisation of resistance mechanisms, sequence typing and phylotyping was performed by polymerase chain reaction (PCR) and sequencing with bacterial DNA extracted from isolates. No CPE was detected. Eleven ESBL Escherichia coli isolates belonging to four phylogenetic groups were detected, including ten CTX-M-15 and one CTX-M-14. The overall gut colonisation with ESBL-producing bacteria (13.25 %) was 6-fold higher than that reported in soldiers in the suburbs of Paris in 2009. ESBL faecal carriage was particularly high (34.48 %) in soldiers repatriated from Afghanistan (risk ratio = 18.62; p = 0.0001). This study highlights the importance of systematic additional contact precautions and CPE/ESBL screening in soldiers repatriated from overseas in French hospitals.
Collapse
Affiliation(s)
- F Janvier
- Service de Microbiologie et Hygiène hospitalière, Hôpital d'Instruction des Armées Bégin, Saint Mandé, France,
| | | | | | | | | | | | | | | |
Collapse
|
40
|
de Chaumont A, Pierret C, Janvier F, Goudard Y, de Kerangal X, Chapuis O. Mucormycosis: A Rare Complication of an Amputation. Ann Vasc Surg 2014; 28:1035.e15-9. [DOI: 10.1016/j.avsg.2013.10.008] [Citation(s) in RCA: 4] [Impact Index Per Article: 0.4] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 06/30/2013] [Revised: 09/30/2013] [Accepted: 10/17/2013] [Indexed: 11/15/2022]
|
41
|
Larréché S, Bigaillon C, Ficko C, Bousquet A, Janvier F, Garcia C, Sanmartin N, Mérens A, Rapp C. Effectiveness of latex agglutination slide test in the diagnosis of imported invasive amoebiasis in the emergency department. Diagn Microbiol Infect Dis 2013; 77:335-6. [PMID: 24125923 DOI: 10.1016/j.diagmicrobio.2013.09.002] [Citation(s) in RCA: 1] [Impact Index Per Article: 0.1] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Key Words] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 02/19/2013] [Revised: 07/09/2013] [Accepted: 09/02/2013] [Indexed: 10/26/2022]
Abstract
We compared a latex agglutination test (LAT) with enzyme-linked immunosorbent assay and indirect hemagglutination assay in the diagnosis of invasive amoebiasis. A retrospective biological records review has included 639 patients for whom these three serological tests were performed. The sensitivity of the LAT was 97.8% and the specificity was 97%.
Collapse
|
42
|
Flateau C, Janvier F, Delacour H, Males S, Ficko C, Andriamanantena D, Jeannot K, Merens A, Rapp C. Recurrent pyelonephritis due to NDM-1 metallo-beta-lactamase producing Pseudomonas aeruginosa in a patient returning from Serbia, France, 2012. Euro Surveill 2012; 17:20311. [PMID: 23153474] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [MESH Headings] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 06/01/2023] Open
Abstract
We describe the first isolation in France of a New-Delhi metallo-beta-lactamase-1 (NDM-1) producing Pseudomonas aeruginosa. In March 2012, a patient with history of prior hospitalisation in Serbia was diagnosed in France with acute pyelonephritis due to NDM-1 producing P. aeruginosa. Clinical and microbiological cure was obtained under appropriate antibiotic treatment. Two months later, she presented with a recurrence due to the same bacteria, with a favourable evolution. During both hospitalisations, contact isolation precautions were implemented and no cross-transmission was observed.
Collapse
Affiliation(s)
- C Flateau
- Service des maladies infectieuses et tropicales, Hopital d instruction des armees Begin, Saint-Mande, France.
| | | | | | | | | | | | | | | | | |
Collapse
|
43
|
Flateau C, Janvier F, Delacour H, Males S, Ficko C, Andriamanantena D, Jeannot K, Mérens A, Rapp C. Recurrent pyelonephritis due to NDM-1 metallo-beta-lactamase producing Pseudomonas aeruginosa in a patient returning from Serbia, France, 2012. Euro Surveill 2012. [DOI: 10.2807/ese.17.45.20311-en] [Citation(s) in RCA: 19] [Impact Index Per Article: 1.6] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/20/2022] Open
Abstract
We describe the first isolation in France of a New-Delhi metallo-beta-lactamase-1 (NDM-1) producing Pseudomonas aeruginosa. In March 2012, a patient with history of prior hospitalisation in Serbia was diagnosed in France with acute pyelonephritis due to NDM-1 producing P. aeruginosa. Clinical and microbiological cure was obtained under appropriate antibiotic treatment. Two months later, she presented with a recurrence due to the same bacteria, with a favourable evolution. During both hospitalisations, contact isolation precautions were implemented and no cross-transmission was observed.
Collapse
Affiliation(s)
- C Flateau
- Service des maladies infectieuses et tropicales, Hôpital d’instruction des armées Bégin, Saint-Mandé, France
| | - F Janvier
- Service de microbiologie-hygiène, Hôpital d’instruction des armées Bégin, Saint-Mandé, France
| | - H Delacour
- Service de microbiologie-hygiène, Hôpital d’instruction des armées Bégin, Saint-Mandé, France
| | - S Males
- Service de médecine et maladies infectieuses, Hôpital Henri Duffaut, Avignon, France
| | - C Ficko
- Service des maladies infectieuses et tropicales, Hôpital d’instruction des armées Bégin, Saint-Mandé, France
| | - D Andriamanantena
- Service des maladies infectieuses et tropicales, Hôpital d’instruction des armées Bégin, Saint-Mandé, France
| | - K Jeannot
- Centre National de la Résistance aux Antibiotiques, Laboratoire de Bactériologie, Hôpital Jean Minjoz, Besançon, France
| | - A Mérens
- Service de microbiologie-hygiène, Hôpital d’instruction des armées Bégin, Saint-Mandé, France
| | - C Rapp
- Service des maladies infectieuses et tropicales, Hôpital d’instruction des armées Bégin, Saint-Mandé, France
| |
Collapse
|
44
|
Bousquet A, Janvier F, Abi R, Larréché S, Mérens A. [Neisseria meningitidis urethritis]. Med Mal Infect 2012; 42:444-5. [PMID: 22947459 DOI: 10.1016/j.medmal.2012.07.016] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 07/10/2012] [Revised: 07/23/2012] [Accepted: 07/29/2012] [Indexed: 10/27/2022]
|
45
|
Breda R, Janvier F, Macnab C, Rigal S. [Mycobacterium massiliense bone infection]. Med Mal Infect 2011; 42:39-42. [PMID: 22154522 DOI: 10.1016/j.medmal.2011.10.017] [Citation(s) in RCA: 1] [Impact Index Per Article: 0.1] [Reference Citation Analysis] [What about the content of this article? (0)] [MESH Headings] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 09/28/2011] [Revised: 10/14/2011] [Accepted: 10/27/2011] [Indexed: 11/28/2022]
|
46
|
Delacour H, Le Berre JP, Servonnet A, Janvier F, Rault A, Ceppa F, Gardet V. [The old man and the syrup]. Pathol Biol (Paris) 2011; 59:336-338. [PMID: 19896293 DOI: 10.1016/j.patbio.2009.05.008] [Citation(s) in RCA: 1] [Impact Index Per Article: 0.1] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [MESH Headings] [Track Full Text] [Subscribe] [Scholar Register] [Received: 04/22/2009] [Accepted: 05/15/2009] [Indexed: 05/28/2023]
Abstract
Intoxication by glycyrrhizin is a rare cause of hypokalemia. We describe a patient with severe hypokalemia caused by long-term consumption of syrup containing liquorice. The physiopathological mechanism of the intoxication and the differential diagnosis are presented.
Collapse
Affiliation(s)
- H Delacour
- Fédération de Biologie Clinique, Hôpital d'Instruction des Armées Bégin, 69 Avenue de Paris, 94163 Saint-Mandé cedex, France
| | | | | | | | | | | | | |
Collapse
|
47
|
Fabre M, Vong R, Zrara A, Saint-Blancard P, Mechaï F, Gérome P, Janvier F, Boudhas A, Soler C. Performances du test « Amplified Mycobacterium Tuberculosis Direct Test » sur les échantillons extrarespiratoires (étude sur 1538 échantillons). ACTA ACUST UNITED AC 2011; 59:29-31. [DOI: 10.1016/j.patbio.2010.08.006] [Citation(s) in RCA: 1] [Impact Index Per Article: 0.1] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 08/03/2010] [Accepted: 08/06/2010] [Indexed: 10/18/2022]
|
48
|
Fabre M, Vong R, Gaillard T, Merens A, Gérome P, Saint-Blancard P, Mechaï F, Janvier F, Nouridjan F, Soler C. [Evaluation of the SD BIOLINE TB Ag MPT64 Rapid® for the diagnosis of tuberculosis]. ACTA ACUST UNITED AC 2011; 59:26-8. [PMID: 21277702 DOI: 10.1016/j.patbio.2010.08.007] [Citation(s) in RCA: 6] [Impact Index Per Article: 0.5] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 08/03/2010] [Accepted: 08/06/2010] [Indexed: 11/29/2022]
Abstract
The purpose of this study was to evaluate the SD Bioline Ag MPT64 Rapid(®) for identification of the Mycobacterium tuberculosis complex. The method uses an immunochromatographic assay and needs 100 μl of sample taken from liquid culture or colonies suspended. The sensitivity was determined using 99 strains of M. tuberculosis complex and the specificity using 10 nontuberculous mycobacteria and 85 strains other than mycobacteria genus. The test showed excellent sensitivity (99%) and specificity (100%). This technique displays several advantages and is destined to spread in all laboratories and particularly in endemic areas.
Collapse
Affiliation(s)
- M Fabre
- Service de biologie médicale, HIA Percy, 101, avenue H.-Barbusse, 92141 Clamart, France.
| | | | | | | | | | | | | | | | | | | |
Collapse
|
49
|
Janvier F, Servonnet A, Delacour H, Fontan E, Ceppa F, Burnat P. [Value of assaying adenosine deaminase level in patients with neuromeningeal tuberculosis]. Med Trop (Mars) 2010; 70:88-93. [PMID: 20337125] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [MESH Headings] [Subscribe] [Scholar Register] [Indexed: 05/29/2023]
Abstract
Neuromeningeal tuberculosis is a rare extrapulmonary location in France. Delayed diagnosis can lead to therapeutic failure and severe sequels. However early diagnosis is a major challenge that requires the proper epidemiological, clinical, radiological and biological resources. Problems related to diagnosis of mycobacteria infection and to shortcomings in certain healthcare systems can hinder early diagnosis. The purpose of this review was to describe the diagnostic value of assaying adenosine deaminase activity in cerebrospinal fluid from patients with neuromeningeal tuberculosis. Evidence from studies published over the last 25 years indicate that the sensitivity and specificity of measuring adenosine deaminase activity range from 36 to 92% and 71 to 100% respectively depending of cutoff values used. Before performing this assay, it is necessary to rule out obvious or frequent etiologies such as purulent bacterial meningitis or cryptococcosis in HIV patients. Taken together these studies show that this simple, inexpensive technique is a valuable tool for early diagnosis and management of tuberculosis patients and that it can be easily implemented in hospital labs regardless of technical or financial resources.
Collapse
Affiliation(s)
- F Janvier
- Fédération de biologie clinique, Hôpital d'Instruction des Armées Bégin, Saint Mandé.
| | | | | | | | | | | |
Collapse
|
50
|
Libert N, De Rudnicki S, Cirodde A, Janvier F, Leclerc T, Borne M, Brinquin L. [Promotility drugs use in critical care: indications and limits?]. ACTA ACUST UNITED AC 2009; 28:962-75. [PMID: 19910155 DOI: 10.1016/j.annfar.2009.08.008] [Citation(s) in RCA: 2] [Impact Index Per Article: 0.1] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 01/14/2009] [Accepted: 08/20/2009] [Indexed: 02/08/2023]
Abstract
Enteral feeding is often limited by gastric and intestinal motility disturbances in critically ill patients, particularly in patients with shock. So, promotility agents are frequently used to improve tolerance to enteral nutrition. This review summaries the pathophysiology, presents the available pharmacological strategies, the clinical data, the counter-indications and the principal limits. The clinical data are poor. No study demonstrates a positive effect on clinical outcomes. Metoclopramide and erythromycin seems to be the more effective. Considering the risk of antibiotic resistance, the first line use of erythromycin should be avoided in favor of metoclopramide.
Collapse
Affiliation(s)
- N Libert
- Département d'anesthésie réanimation, hôpital d'instruction des armées du Val-de-Grâce,74, boulevard de Port-Royal, 750005 Paris, France.
| | | | | | | | | | | | | |
Collapse
|